In-hospital and long-term outcome of patients with mitral valve replacement with and without retethering technique

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00032902

Enrollment

Registered

2023-11-06

Start date

2023-11-10

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

mitral valve replacement

Interventions

Group 1: The aim of this study is to examine the findings of patients who have had a mitral valve replacement with and without retethering since 2017. In addition, the findings of all patients who wil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Patients who have had mitral valve replacement surgery since 2017

Exclusion criteria

Exclusion criteria: • Lack of patient consent

Design outcomes

Primary

Measure	Time frame
Leftventricular ejectionfraction after 12 months	—

Secondary

Measure	Time frame
Secondary endpoints will be: 1. Patient mortality (up to 3 years) 2. Frequency of an LVR 3. Echocardiographic data on ventricle and valve function before surgery and in the short and long term as well as integrity of the patch (intrahospital , 30 days, 6 months, 1 year, max. 3 years if applicable) 4. Frequency of secondary bleeding and reoperation during hospital stay 5. Rate of pacemaker requirement during hospital stay 6. Length of hospital stay 8. Course parameters of the hospital stay: laboratory values, transfusions	—

Measure

Time frame

Secondary endpoints will be: 1. Patient mortality (up to 3 years) 2. Frequency of an LVR 3. Echocardiographic data on ventricle and valve function before surgery and in the short and long term as well as integrity of the patch (intrahospital , 30 days, 6 months, 1 year, max. 3 years if applicable) 4. Frequency of secondary bleeding and reoperation during hospital stay 5. Rate of pacemaker requirement during hospital stay 6. Length of hospital stay 8. Course parameters of the hospital stay: laboratory values, transfusions

—

Countries

Germany

Contacts

Public ContactMax Wacker

Universitätsklinikum Magdeburg A.ö.R. Klinik für Herz- und Thoraxchirurgie

max.wacker@med.ovgu.de+49 391-67-24903

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026